255 related articles for article (PubMed ID: 19250205)
1. Targeting aromatase and estrogen signaling in human non-small cell lung cancer.
Márquez-Garbán DC; Chen HW; Goodglick L; Fishbein MC; Pietras RJ
Ann N Y Acad Sci; 2009 Feb; 1155():194-205. PubMed ID: 19250205
[TBL] [Abstract][Full Text] [Related]
2. Co-expression of estrogen receptor beta and aromatase in Japanese lung cancer patients: gender-dependent clinical outcome.
Verma MK; Miki Y; Abe K; Nagasaki S; Niikawa H; Suzuki S; Kondo T; Sasano H
Life Sci; 2012 Oct; 91(15-16):800-8. PubMed ID: 22982181
[TBL] [Abstract][Full Text] [Related]
3. [Advances in Association of Estrogen and Human Non-small Cell Lung Cancer].
He J; Song X
Zhongguo Fei Ai Za Zhi; 2015 May; 18(5):315-20. PubMed ID: 25975303
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma.
Niikawa H; Suzuki T; Miki Y; Suzuki S; Nagasaki S; Akahira J; Honma S; Evans DB; Hayashi S; Kondo T; Sasano H
Clin Cancer Res; 2008 Jul; 14(14):4417-26. PubMed ID: 18579664
[TBL] [Abstract][Full Text] [Related]
5. Aromatase inhibitors in human lung cancer therapy.
Weinberg OK; Marquez-Garban DC; Fishbein MC; Goodglick L; Garban HJ; Dubinett SM; Pietras RJ
Cancer Res; 2005 Dec; 65(24):11287-91. PubMed ID: 16357134
[TBL] [Abstract][Full Text] [Related]
6. Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.
Siegfried JM; Farooqui M; Rothenberger NJ; Dacic S; Stabile LP
Oncotarget; 2017 Apr; 8(15):24063-24076. PubMed ID: 28445992
[TBL] [Abstract][Full Text] [Related]
7. Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer.
Marquez-Garban DC; Mah V; Alavi M; Maresh EL; Chen HW; Bagryanova L; Horvath S; Chia D; Garon E; Goodglick L; Pietras RJ
Steroids; 2011 Aug; 76(9):910-20. PubMed ID: 21600232
[TBL] [Abstract][Full Text] [Related]
8. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
Raben D; Helfrich B; Chan DC; Ciardiello F; Zhao L; Franklin W; Barón AE; Zeng C; Johnson TK; Bunn PA
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):795-805. PubMed ID: 15701870
[TBL] [Abstract][Full Text] [Related]
9. Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.
Stabile LP; Lyker JS; Gubish CT; Zhang W; Grandis JR; Siegfried JM
Cancer Res; 2005 Feb; 65(4):1459-70. PubMed ID: 15735034
[TBL] [Abstract][Full Text] [Related]
10. Aromatase in human lung carcinoma.
Verma MK; Miki Y; Sasano H
Steroids; 2011 Jul; 76(8):759-64. PubMed ID: 21392519
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptors, antiestrogens, and non-small cell lung cancer.
Bogush TA; Dudko EA; Beme AA; Bogush EA; Kim AI; Polotsky BE; Tjuljandin SA; Davydov MI
Biochemistry (Mosc); 2010 Dec; 75(12):1421-7. PubMed ID: 21314611
[TBL] [Abstract][Full Text] [Related]
12. [Recent Advances in Association of Estrogen and Non-small Cell Lung Cancer].
Ding X; Tang C; Wang Z; Liang J
Zhongguo Fei Ai Za Zhi; 2017 Jul; 20(7):499-504. PubMed ID: 28738967
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor signaling pathways in human non-small cell lung cancer.
Márquez-Garbán DC; Chen HW; Fishbein MC; Goodglick L; Pietras RJ
Steroids; 2007 Feb; 72(2):135-43. PubMed ID: 17276470
[TBL] [Abstract][Full Text] [Related]
14. Aromatase expression predicts survival in women with early-stage non small cell lung cancer.
Mah V; Seligson DB; Li A; Márquez DC; Wistuba II; Elshimali Y; Fishbein MC; Chia D; Pietras RJ; Goodglick L
Cancer Res; 2007 Nov; 67(21):10484-90. PubMed ID: 17974992
[TBL] [Abstract][Full Text] [Related]
15. Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer.
Mah V; Marquez D; Alavi M; Maresh EL; Zhang L; Yoon N; Horvath S; Bagryanova L; Fishbein MC; Chia D; Pietras R; Goodglick L
Lung Cancer; 2011 Nov; 74(2):318-25. PubMed ID: 21511357
[TBL] [Abstract][Full Text] [Related]
16. Aromatase inhibitors and their antitumor effects in model systems.
Brodie A; Lu Q; Liu Y; Long B
Endocr Relat Cancer; 1999 Jun; 6(2):205-10. PubMed ID: 10731110
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
Pietras RJ; Márquez DC; Chen HW; Tsai E; Weinberg O; Fishbein M
Steroids; 2005; 70(5-7):372-81. PubMed ID: 15862820
[TBL] [Abstract][Full Text] [Related]
18. Suppression of estrogen actions in human lung cancer.
Miki Y; Abe K; Suzuki S; Suzuki T; Sasano H
Mol Cell Endocrinol; 2011 Jul; 340(2):168-74. PubMed ID: 21354461
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model.
Raben D; Bianco C; Damiano V; Bianco R; Melisi D; Mignogna C; D'Armiento FP; Cionini L; Bianco AR; Tortora G; Ciardiello F; Bunn P
Mol Cancer Ther; 2004 Aug; 3(8):977-83. PubMed ID: 15299080
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone suppresses the growth of human non-small cell lung cancer via inducing estrogen sulfotransferase and inactivating estrogen.
Wang LJ; Li J; Hao FR; Yuan Y; Li JY; Lu W; Zhou TY
Acta Pharmacol Sin; 2016 Jun; 37(6):845-56. PubMed ID: 27133297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
